文献速递头颈部肿瘤放疗姑息放疗与转移瘤

儿童及青少年鼻咽癌幸存者放疗后远期后遗症分析

Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-09-20

该研究回顾了1991年2月至2010年10月在中山大学肿瘤防治中心治疗的94例18岁以下鼻咽癌幸存者,中位随访10年(5-27年)。与常规放疗相比,调强放疗幸存者的口干、吞咽困难和慢性中耳炎累积发生率显著降低;原发肿瘤剂量>72 Gy者听力损失、言语障碍和脑神经损伤累积发生率显著高于60-72 Gy者;年龄<10岁者视物模糊累积发生率较高。

要点

  • 调强放疗较常规放疗显著降低口干、吞咽困难和慢性中耳炎累积发生率。
  • 鼻咽剂量>72 Gy者听力损失、言语障碍和脑神经损伤累积发生率显著高于60-72 Gy者。
  • 年龄<10岁者视物模糊累积发生率为33.3%,高于10-18岁者的2.3%(P = .006)。

核心结论

  • 与常规放疗相比,调强放疗可能改善口干、吞咽困难和慢性中耳炎。
  • 年龄<10岁患者视物模糊累积发生率较高。
  • 原发肿瘤剂量>72 Gy增加听力损失、言语障碍和脑神经损伤累积发生率。

研究设计与样本

  • 回顾性分析1991年2月至2010年10月在中山大学肿瘤防治中心治疗的94例18岁以下鼻咽癌幸存者的病历资料。
  • 采用χ2检验和二元回归分析比较不同组幸存者治疗合并症累积发生率。
  • 中位随访时间10年(5-27年)。

主要发现

  • 调强放疗幸存者口干、吞咽困难和慢性中耳炎累积发生率较常规放疗幸存者显著降低。
  • 年龄<10岁患者视物模糊累积发生率为33.3%,10-18岁患者为2.3%(P = .006)。
  • 鼻咽剂量>72 Gy者听力损失累积发生率显著高于60-72 Gy者(P = .008)。
  • 鼻咽剂量>72 Gy者言语障碍累积发生率显著高于60-72 Gy者(P = .013)。
  • 鼻咽剂量>72 Gy者脑神经损伤累积发生率显著高于60-72 Gy者(P = .029)。

关键数值与推荐

  • 94例幸存者中,22%体重指数低于18.5。
  • 女性幸存者中11/16(62.5%)存在月经或生育问题。
  • 59例幸存者有身高、体重、教育水平、年收入、婚姻和生育状态及月经状态记录。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The objective of this study was to reveal the long-term sequelae in survivors of childhood and adolescent nasopharyngeal carcinoma after radiation therapy. METHODS AND MATERIALS: We reviewed the medical records of patients aged <18 years with nasopharyngeal carcinoma who were treated at Sun Yat-sen University Cancer Center from February 1991 to October 2010. Data concerning clinical characteristics, treatment, outcomes, and late morbidities were extracted. We used χ2 tests and binary regression analysis to compare the cumulative incidence (CI) of treatment comorbidities among different groups of survivors. RESULTS: A total of 94 patients survived. They had a median follow-up time of 10 years (5-27 years). Compared with the CI of survivors treated with conventional radiation therapy treatment, the CI of xerostomia, dysphagia, and chronic otitis media was significantly decreased in the survivors treated with intensity modulated radiation therapy treatment. The CI of blurred vision in patients younger than 10 years and in patients 10 to 18 years old were 33.3% and 2.3%, respectively (P = .006). Survivors who received a nasopharynx dose >72 Gy, compared with a nasopharynx dose of 60 to 72 Gy, had a significantly higher CI of hearing loss (P = .008), lalopathy (P = .013), and cranial nerve injury (P = .029). We also had records of height, weight, education level, annual income, marital and fertility status, and menstruation state for 59 of the survivors. Twenty-two percent of the survivors had a body mass index lower than 18.5. Among the female survivors, 11 of 16 (62.5%) had menstrual or fertility problems. CONCLUSIONS: Compared with convention radiation therapy treatment, intensity modulated radiation therapy treatment can potentially ameliorate xerostomia, dysphagia, and chronic otitis media. In addition, patients younger than 10 years had a higher CI of blurred vision. Moreover, a dose of more than 72 Gy to primary tumor increased the CI of hearing loss, lalopathy, and cranial nerve injury.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Lu S, Wei J, Sun F, et al. Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 30244159. doi:10.1016/j.ijrobp.2018.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。